Tapewire

Nasdaq · USD

GEHC

GE HealthCare Technologies Inc.

Export transactions ↓
Tapewire entity
1711
SEC CIK
0001932393
Parsed reports
254

Last 12 months

Inside the activity.

8 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202620
May 202660
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 07, 2024 Filed Aug 7, 2024 22:18 UTC
Westrick Thomas J.CEO, Patient Care Solutions
SaleCommon Stock, par value $0.01 per share 2,750 $80.78 $222,145.00
Disclosure

SEC source: 0001628280-24-035773 · wk-form4_1723069129.xml · nonDerivative · entry 1

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,509

F1 · price: The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $80.78 to $80.84, inclusive. The Reporting Person undertakes to provide to GE HealthCare Technologies Inc. ("GE HealthCare"), any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).

Read SEC document
August 03, 2024 Filed Aug 6, 2024 20:05 UTC
Rott RolandCEO, Imaging
Tax withholdingCommon Stock, par value $0.01 per share 1,630 $83.44 $136,007.20
Disclosure

SEC source: 0001628280-24-035175 · wk-form4_1722974736.xml · nonDerivative · entry 1

Rott Roland · CIK 0001952159 · CEO, Imaging

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,199

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Read SEC document
August 03, 2024 Filed Aug 6, 2024 20:05 UTC Tax withholdingCommon Stock, par value $0.01 per share 1,533 $83.44 $127,913.52
Disclosure

SEC source: 0001628280-24-035172 · wk-form4_1722974712.xml · nonDerivative · entry 1

O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,477

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Read SEC document
June 01, 2024 Filed Jun 4, 2024 12:00 UTC
SACCARO JAMESChief Financial Officer
Tax withholdingCommon Stock, par value $0.01 per share 8,998 $78.00 $701,844.00
Disclosure

SEC source: 0001628280-24-026476 · wk-form4_1717502409.xml · nonDerivative · entry 1

SACCARO JAMES · CIK 0001593636 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,940

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Read SEC document
May 28, 2024 Filed May 29, 2024 20:05 UTC
Kass-Hout TahaChief Technology Officer
SaleCommon Stock, par value $0.01 per share 3,300 $78.70 $259,710.00
Disclosure

SEC source: 0001628280-24-025602 · wk-form4_1717013112.xml · nonDerivative · entry 1

Kass-Hout Taha · CIK 0001960652 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,300

F1 · price: The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $78.70 to $78.72, inclusive. The Reporting Person undertakes to provide to GE HealthCare Technologies Inc. ("GE HealthCare"), any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).

Read SEC document
May 21, 2024 Filed May 23, 2024 20:32 UTC GrantCommon Stock, par value $0.01 per share 2,440 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-024965 · wk-form4_1716496324.xml · nonDerivative · entry 1

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,065

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 21, 2025. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the director's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

Read SEC document
May 21, 2024 Filed May 23, 2024 20:33 UTC GrantCommon Stock, par value $0.01 per share 1,525 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-024968 · wk-form4_1716496379.xml · nonDerivative · entry 2

Madden Anne T · CIK 0001684059 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,763

F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F3 · shares: Award of fully vested deferred stock units with respect to GE HealthCare common stock. The reporting person elected, in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan, to receive fully vested deferred stock units in lieu of 100% of the cash retainer awarded to the reporting person. Settlement will occur pursuant to the director's applicable deferral election.

Read SEC document
May 21, 2024 Filed May 23, 2024 20:33 UTC GrantCommon Stock, par value $0.01 per share 2,440 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-024968 · wk-form4_1716496379.xml · nonDerivative · entry 1

Madden Anne T · CIK 0001684059 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,238

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 21, 2025. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the director's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.

F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

Read SEC document
May 21, 2024 Filed May 23, 2024 20:31 UTC GrantCommon Stock, par value $0.01 per share 1,525 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-024963 · wk-form4_1716496251.xml · nonDerivative · entry 2

Hochman Rodney F · CIK 0001468966 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,763

F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F3 · shares: Award of fully vested deferred stock units with respect to GE HealthCare common stock. The reporting person elected, in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan, to receive fully vested deferred stock units in lieu of 100% of the cash retainer awarded to the reporting person. Settlement will occur pursuant to the director's applicable deferral election.

Read SEC document
May 21, 2024 Filed May 23, 2024 20:31 UTC GrantCommon Stock, par value $0.01 per share 2,440 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-024963 · wk-form4_1716496251.xml · nonDerivative · entry 1

Hochman Rodney F · CIK 0001468966 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,238

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 21, 2025. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the director's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.

F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

Read SEC document
May 21, 2024 Filed May 23, 2024 20:34 UTC GrantCommon Stock, par value $0.01 per share 1,769 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-024973 · wk-form4_1716496466.xml · nonDerivative · entry 2

Stromberg William J · CIK 0001352578 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,201

F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F3 · shares: Award of fully vested deferred stock units with respect to GE HealthCare common stock. The reporting person elected, in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan, to receive fully vested deferred stock units in lieu of 100% of the cash retainer awarded to the reporting person. Settlement will occur pursuant to the director's applicable deferral election.

Read SEC document
May 21, 2024 Filed May 23, 2024 20:34 UTC GrantCommon Stock, par value $0.01 per share 2,440 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-024973 · wk-form4_1716496466.xml · nonDerivative · entry 1

Stromberg William J · CIK 0001352578 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,432

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 21, 2025. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the director's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.

F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

Read SEC document
May 21, 2024 Filed May 23, 2024 20:30 UTC GrantCommon Stock, par value $0.01 per share 2,440 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-024961 · wk-form4_1716496211.xml · nonDerivative · entry 1

CULP H LAWRENCE JR · CIK 0001205247 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 624,074

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 21, 2025. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the director's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

Read SEC document
May 21, 2024 Filed May 23, 2024 20:32 UTC GrantCommon Stock, par value $0.01 per share 2,440 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-024967 · wk-form4_1716496353.xml · nonDerivative · entry 1

LESJAK CATHERINE A · CIK 0001256992 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,024

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 21, 2025. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the director's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

Read SEC document
May 21, 2024 Filed May 23, 2024 16:31 UTC GrantCommon Stock, par value $0.01 per share 2,440 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-024964 · wk-form4_1716496284.xml · nonDerivative · entry 1

HOWELL LLOYD JR · CIK 0001505488 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,024

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 21, 2025. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the director's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

Read SEC document
May 21, 2024 Filed May 23, 2024 20:34 UTC GrantCommon Stock, par value $0.01 per share 2,440 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-024971 · wk-form4_1716496434.xml · nonDerivative · entry 1

Mihaljevic Tomislav · CIK 0001917584 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,024

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 21, 2025. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the director's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

Read SEC document
May 21, 2024 Filed May 23, 2024 20:35 UTC GrantCommon Stock, par value $0.01 per share 2,440 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-024975 · wk-form4_1716496489.xml · nonDerivative · entry 1

Yang Watkin Phoebe L. · CIK 0001940538 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,024

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 21, 2025. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the director's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

Read SEC document
May 15, 2024 Filed May 15, 2024 23:15 UTC
Makela JanCEO, Imaging
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 33,095 $0.00 Strike: $76.37 $0.00
Disclosure

SEC source: 0001628280-24-023668 · wk-form4_1715814910.xml · derivative · entry 10

Makela Jan · CIK 0001951803 · CEO, Imaging

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,096

Underlying: Common Stock, par value $0.01 per share · 33,095 shares

Expires 2031-07-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% became exercisable on July 1, 2023 and 50% will become exercisable on July 1, 2024.

Read SEC document
May 15, 2024 Filed May 15, 2024 23:15 UTC
Makela JanCEO, Imaging
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 25,472 $0.00 Strike: $75.30 $0.00
Disclosure

SEC source: 0001628280-24-023668 · wk-form4_1715814910.xml · derivative · entry 9

Makela Jan · CIK 0001951803 · CEO, Imaging

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, par value $0.01 per share · 25,472 shares

Expires 2033-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 100% became exercisable on March 1, 2024.

Read SEC document
May 15, 2024 Filed May 15, 2024 23:15 UTC
Makela JanCEO, Imaging
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 8,388 $0.00 Strike: $63.51 $0.00
Disclosure

SEC source: 0001628280-24-023668 · wk-form4_1715814910.xml · derivative · entry 8

Makela Jan · CIK 0001951803 · CEO, Imaging

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, par value $0.01 per share · 8,388 shares

Expires 2030-03-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% became exercisable on March 2, 2023.

Read SEC document
May 15, 2024 Filed May 15, 2024 23:15 UTC
Makela JanCEO, Imaging
SaleCommon Stock, par value $0.01 per share 66,955 $81.54 $5,459,510.70
Disclosure

SEC source: 0001628280-24-023668 · wk-form4_1715814910.xml · nonDerivative · entry 6

Makela Jan · CIK 0001951803 · CEO, Imaging

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,348

F2 · price: The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $81.50 to $81.68, inclusive. The Reporting Person undertakes to provide GE HealthCare, any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).

Read SEC document
May 15, 2024 Filed May 15, 2024 23:15 UTC
Makela JanCEO, Imaging
Exercise / conversionCommon Stock, par value $0.01 per share 33,095 $76.37 $2,527,465.15
Disclosure

SEC source: 0001628280-24-023668 · wk-form4_1715814910.xml · nonDerivative · entry 5

Makela Jan · CIK 0001951803 · CEO, Imaging

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 130,303

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 15, 2024 Filed May 15, 2024 23:15 UTC
Makela JanCEO, Imaging
Exercise / conversionCommon Stock, par value $0.01 per share 25,472 $75.30 $1,918,041.60
Disclosure

SEC source: 0001628280-24-023668 · wk-form4_1715814910.xml · nonDerivative · entry 4

Makela Jan · CIK 0001951803 · CEO, Imaging

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,208

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 15, 2024 Filed May 15, 2024 23:15 UTC
Makela JanCEO, Imaging
Exercise / conversionCommon Stock, par value $0.01 per share 8,388 $63.51 $532,721.88
Disclosure

SEC source: 0001628280-24-023668 · wk-form4_1715814910.xml · nonDerivative · entry 3

Makela Jan · CIK 0001951803 · CEO, Imaging

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,736

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 13, 2024 Filed May 15, 2024 23:15 UTC
Makela JanCEO, Imaging
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 20,227 $0.00 Strike: $63.51 $0.00
Disclosure

SEC source: 0001628280-24-023668 · wk-form4_1715814910.xml · derivative · entry 7

Makela Jan · CIK 0001951803 · CEO, Imaging

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,388

Underlying: Common Stock, par value $0.01 per share · 20,227 shares

Expires 2030-03-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% became exercisable on March 2, 2023.

Read SEC document
May 13, 2024 Filed May 15, 2024 23:15 UTC
Makela JanCEO, Imaging
SaleCommon Stock, par value $0.01 per share 20,227 $81.57 $1,649,916.39
Disclosure

SEC source: 0001628280-24-023668 · wk-form4_1715814910.xml · nonDerivative · entry 2

Makela Jan · CIK 0001951803 · CEO, Imaging

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,348

F1 · price: The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $81.50 to $81.84, inclusive. The Reporting Person undertakes to provide GE HealthCare Technologies Inc. ("GE HealthCare"), any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).

Read SEC document
May 13, 2024 Filed May 15, 2024 23:15 UTC
Makela JanCEO, Imaging
Exercise / conversionCommon Stock, par value $0.01 per share 20,227 $63.51 $1,284,616.77
Disclosure

SEC source: 0001628280-24-023668 · wk-form4_1715814910.xml · nonDerivative · entry 1

Makela Jan · CIK 0001951803 · CEO, Imaging

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,575

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 01, 2024 Filed May 2, 2024 10:00 UTC
Jimenez Frank RGC & Corporate Secretary
PurchaseCommon Stock, par value $0.01 per share 1,315 $76.52 $100,623.80
Disclosure

SEC source: 0001628280-24-019724 · wk-form4_1714644029.xml · nonDerivative · entry 1

Jimenez Frank R · CIK 0001465175 · GC & Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,796

Read SEC document
April 01, 2024 Filed Apr 2, 2024 22:41 UTC
Rott RolandCEO, Ultrasound
Tax withholdingCommon Stock, par value $0.01 per share 837 $90.91 $76,091.67
Disclosure

SEC source: 0001628280-24-014445 · wk-form4_1712097697.xml · nonDerivative · entry 1

Rott Roland · CIK 0001952159 · CEO, Ultrasound

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,829

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Read SEC document
March 15, 2024 Filed Mar 15, 2024 20:03 UTC
GENERAL ELECTRIC COFormer 10% Owner
OtherCommon stock, par value $0.01 per share 14,000,000 Not disclosed Not disclosed
Disclosure

SEC source: 0000950142-24-000720 · es240458409_4-ge.xml · nonDerivative · entry 1

GENERAL ELECTRIC CO · CIK 0000040545 · Former 10% Owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,631,302

F1 · security: The reporting person exchanged 14,000,000 shares of the common stock of the Issuer to extinguish $1,221,780,000 aggregate principal amount of indebtedness under a short-term credit facility of the reporting person in a debt-for-equity exchange.

F1 · kind: The reporting person exchanged 14,000,000 shares of the common stock of the Issuer to extinguish $1,221,780,000 aggregate principal amount of indebtedness under a short-term credit facility of the reporting person in a debt-for-equity exchange.

F2 · price: The value of the Issuer's common stock for purposes of the debt-for-equity exchange was $87.27 per share.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 17:55 UTC
Stacherski Kenneth R.Ch. Supply Chain & Serv. Ofc.
GrantEmployee Stock Option (right to buy) · Derivative 13,420 $0.00 Strike: $92.72 $0.00
Disclosure

SEC source: 0001628280-24-009085 · wk-form4_1709679338.xml · derivative · entry 2

Stacherski Kenneth R. · CIK 0001889865 · Ch. Supply Chain & Serv. Ofc.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,420

Underlying: Common Stock, par value $0.01 per share · 13,420 shares

Expires 2034-03-01

F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions.

F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 17:55 UTC
Stacherski Kenneth R.Ch. Supply Chain & Serv. Ofc.
GrantCommon Stock, par value $0.01 per share 4,718 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-009085 · wk-form4_1709679338.xml · nonDerivative · entry 1

Stacherski Kenneth R. · CIK 0001889865 · Ch. Supply Chain & Serv. Ofc.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,549

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 33% will vest on September 1, 2025, 33% will vest on September 1, 2026, and 34% will vest on September 1, 2027, subject to certain conditions.

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 22:51 UTC
Jimenez Frank RGC & Corporate Secretary
GrantEmployee Stock Option (right to buy) · Derivative 26,840 $0.00 Strike: $92.72 $0.00
Disclosure

SEC source: 0001628280-24-009072 · wk-form4_1709679097.xml · derivative · entry 4

Jimenez Frank R · CIK 0001465175 · GC & Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,840

Underlying: Common Stock, par value $0.01 per share · 26,840 shares

Expires 2034-03-01

F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions.

F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 22:51 UTC
Jimenez Frank RGC & Corporate Secretary
GrantCommon Stock, par value $0.01 per share 9,437 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-009072 · wk-form4_1709679097.xml · nonDerivative · entry 3

Jimenez Frank R · CIK 0001465175 · GC & Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,481

F2 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 1, 2025, 33% will vest on September 1, 2026, and 34% will vest on September 1, 2027, subject to certain conditions.

F3 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 22:51 UTC
Jimenez Frank RGC & Corporate Secretary
Tax withholdingCommon Stock, par value $0.01 per share 4,841 $91.28 $441,886.48
Disclosure

SEC source: 0001628280-24-009072 · wk-form4_1709679097.xml · nonDerivative · entry 2

Jimenez Frank R · CIK 0001465175 · GC & Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,044

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 22:51 UTC
Jimenez Frank RGC & Corporate Secretary
Tax withholdingCommon Stock, par value $0.01 per share 6,443 $91.28 $588,117.04
Disclosure

SEC source: 0001628280-24-009072 · wk-form4_1709679097.xml · nonDerivative · entry 1

Jimenez Frank R · CIK 0001465175 · GC & Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,885

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 22:50 UTC Tax withholdingCommon Stock, par value $0.01 per share 31,290 $91.28 $2,856,151.20
Disclosure

SEC source: 0001628280-24-009067 · wk-form4_1709679019.xml · nonDerivative · entry 1

CULP H LAWRENCE JR · CIK 0001205247 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 621,634

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of performance stock units previously reported by the reporting person in the Form 4 filed with the Securities and Exchange Commission on December 29, 2023.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 22:51 UTC
Arduini Peter JDirector · President and CEO
GrantEmployee Stock Option (right to buy) · Derivative 103,527 $0.00 Strike: $92.72 $0.00
Disclosure

SEC source: 0001628280-24-009069 · wk-form4_1709679058.xml · derivative · entry 3

Arduini Peter J · CIK 0001323134 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 103,527

Underlying: Common Stock, par value $0.01 per share · 103,527 shares

Expires 2034-03-01

F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions.

F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 22:51 UTC
Arduini Peter JDirector · President and CEO
GrantCommon Stock, par value $0.01 per share 36,399 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-009069 · wk-form4_1709679058.xml · nonDerivative · entry 2

Arduini Peter J · CIK 0001323134 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 113,200

F2 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 1, 2025, 33% will vest on September 1, 2026, and 34% will vest on September 1, 2027, subject to certain conditions.

F3 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 22:51 UTC
Arduini Peter JDirector · President and CEO
Tax withholdingCommon Stock, par value $0.01 per share 4,444 $91.28 $405,648.32
Disclosure

SEC source: 0001628280-24-009069 · wk-form4_1709679058.xml · nonDerivative · entry 1

Arduini Peter J · CIK 0001323134 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,801

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 22:55 UTC
SACCARO JAMESChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 29,141 $0.00 Strike: $92.72 $0.00
Disclosure

SEC source: 0001628280-24-009083 · wk-form4_1709679314.xml · derivative · entry 2

SACCARO JAMES · CIK 0001593636 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,141

Underlying: Common Stock, par value $0.01 per share · 29,141 shares

Expires 2034-03-01

F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions.

F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 22:55 UTC
SACCARO JAMESChief Financial Officer
GrantCommon Stock, par value $0.01 per share 10,245 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-009083 · wk-form4_1709679314.xml · nonDerivative · entry 1

SACCARO JAMES · CIK 0001593636 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,938

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 33% will vest on September 1, 2025, 33% will vest on September 1, 2026, and 34% will vest on September 1, 2027, subject to certain conditions.

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 22:53 UTC
Larson Betty DChief People Officer
Tax withholdingCommon Stock, par value $0.01 per share 3,523 $91.28 $321,579.44
Disclosure

SEC source: 0001628280-24-009076 · wk-form4_1709679168.xml · nonDerivative · entry 2

Larson Betty D · CIK 0001617903 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,936

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 22:53 UTC
Larson Betty DChief People Officer
Tax withholdingCommon Stock, par value $0.01 per share 7,472 $91.28 $682,044.16
Disclosure

SEC source: 0001628280-24-009076 · wk-form4_1709679168.xml · nonDerivative · entry 1

Larson Betty D · CIK 0001617903 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,459

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 22:56 UTC
Westrick Thomas J.CEO, Patient Care Solutions
GrantEmployee Stock Option (right to buy) · Derivative 8,435 $0.00 Strike: $92.72 $0.00
Disclosure

SEC source: 0001628280-24-009086 · wk-form4_1709679363.xml · derivative · entry 6

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,435

Underlying: Common Stock, par value $0.01 per share · 8,435 shares

Expires 2034-03-01

F5 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions.

F5 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 22:56 UTC
Westrick Thomas J.CEO, Patient Care Solutions
GrantCommon Stock, par value $0.01 per share 2,965 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-009086 · wk-form4_1709679363.xml · nonDerivative · entry 5

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,259

F3 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 1, 2025, 33% will vest on September 1, 2026, and 34% will vest on September 1, 2027, subject to certain conditions.

F4 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 22:56 UTC
Westrick Thomas J.CEO, Patient Care Solutions
Tax withholdingCommon Stock, par value $0.01 per share 2,121 $91.28 $193,604.88
Disclosure

SEC source: 0001628280-24-009086 · wk-form4_1709679363.xml · nonDerivative · entry 4

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,294

F2 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of performance stock units previously reported by the reporting person in the Form 4 filed with the Securities and Exchange Commission on December 29, 2023.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 22:56 UTC
Westrick Thomas J.CEO, Patient Care Solutions
Tax withholdingCommon Stock, par value $0.01 per share 1,169 $91.28 $106,706.32
Disclosure

SEC source: 0001628280-24-009086 · wk-form4_1709679363.xml · nonDerivative · entry 3

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,415

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 22:56 UTC
Westrick Thomas J.CEO, Patient Care Solutions
Tax withholdingCommon Stock, par value $0.01 per share 1,285 $91.28 $117,294.80
Disclosure

SEC source: 0001628280-24-009086 · wk-form4_1709679363.xml · nonDerivative · entry 2

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,584

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 22:56 UTC
Westrick Thomas J.CEO, Patient Care Solutions
Tax withholdingCommon Stock, par value $0.01 per share 1,195 $91.28 $109,079.60
Disclosure

SEC source: 0001628280-24-009086 · wk-form4_1709679363.xml · nonDerivative · entry 1

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,869

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.